ProfileGDS4177 / 215489_x_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 66% 61% 74% 71% 55% 49% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated76.5566
GSM603099KU-812 non-treated56.7161
GSM603098KCL-22 Imatinib-treated139.8974
GSM603097KCL-22 non-treated107.4271
GSM603102JURL-MK1 Imatinib-treated41.1455
GSM603101JURL-MK1 non-treated31.6949